NCT05392985已完成不适用
Chemotherapy Versus Endocrine Therapy in Metastatic Breast Cancer Patients With Heterogeneous Estrogen Receptor Expression
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 51
- 试验地点
- 1
- 主要终点
- PFS
研究概览
简要总结
To investigate the treatment pattern and efficacy of MBC patients with ER heterogeneity using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients received 18F-FES PET/CT in Fudan University Shanghai Cancer Center from 2017-
- •Patients had both FES positive (FES+) and negative (FES-) lesions in FES exam.
- •Patients received further treatment.
排除标准
- •Incomplete medical records.
结局指标
主要结局
PFS
时间窗: 6 weeks
Progression free survival
次要结局
- Adverse events(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
3 期
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor PrognosisDiffuse Large B-Cell LymphomaNCT02842931National Research Center for Hematology, Russia300
已完成
2 期
Low Dose Metronomic Poly-chemotherapy for Metastatic CRCColorectal CancerNCT02280694HaEmek Medical Center, Israel45
Unknown
1 期
Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast CancerMetastatic Breast CancerNCT03591276Shaare Zedek Medical Center15
已完成
2 期
Phase II Study of Alternating Sunitinib and TemsirolimusMetastatic Renal Cell CarcinomaNCT01517243Dartmouth-Hitchcock Medical Center37
尚未招募
1 期
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer PatientsFemale Breast CancerNCT05755581Sohag University100